Exhibit 16.1
August 14, 2020
US Securities and Exchange Commission Office of the Chief Accountant 100 F Street, NE Washington, DC 20549 |
| Re: Benitec Biopharma Inc |
| File No. 001-39267 |
Dear Sir or Madam:
We have read the disclosure as it appears under the caption “Change in Auditor” in Form S-1 of Benitec Biopharma Inc. dated August 14, 2020 and are in agreement with the statements contained solely as it relates to our Firm.
Very truly yours,
/s/ GRANT THORNTON AUDIT PTY LTD
Sydney, NSW Australia
August 14, 2020
